EMILY POSTON: Open Payments
NPI 1962266775 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $147 |
| ABBVIE INC. | 4 | $82 |
| Ardelyx, Inc. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: TREMFYA, IBSRELA, DUPIXENT, CREON, INJECTAFER, LINZESS, REZDIFFRA, RINVOQ.
Industry payments across SC — which companies pay providers there.
